Cambridge Day: Health care costs keep rising, but biopharma is not the enemy

By: Neil Kairen

“Living and working in Cambridge with its inspiring biopharma ecosystem continues to give me a sense of purpose. I’ve helped advance drugs through clinical development and ultimately to market, and I’m grateful I’ve supported bringing meaningful therapies to patients in areas such as cancer, autoimmune disease and neurodegenerative conditions, among others.

…

In the past 50 years, the average life span in the United States has increased to 79 years from 72. Globally, this increase has been even more pronounced, rising to 73 years from 58. This roughly 24 percent increase in life span is due largely to advancements in medical procedures and treatments such as antibiotics, vaccines, antihypertensives, insulin, chemo and immunotherapies.”